Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Search in posts
Search in pages
Filter by Categories
Case Report
Clinical research study
Current Issue
Editorial Board
Literature Review
Narrative review
Original Article
Research Article
Review Article
Short Report
Surgical techniques
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Search in posts
Search in pages
Filter by Categories
Case Report
Clinical research study
Current Issue
Editorial Board
Literature Review
Narrative review
Original Article
Research Article
Review Article
Short Report
Surgical techniques
View/Download PDF

Translate this page into:

74 (); 33-38
doi:
10.1016/j.jor.2025.12.056

Patient acceptable symptom state (PASS) thresholds for the Hip disability and Osteoarthritis Outcome Score (HOOS) after total hip arthroplasty

Department of Rehabilitation, Faculty of Health Sciences, Tokyo Kasei University, 2-15-1 Inariyama, Sayama City, Saitama, 350-1398, Japan
Department of Rehabilitation, Saitama Medical Center, Saitama Medical University, 1981 Kamoda, Kawagoe City, Saitama, 350-8550, Japan
Department of Physical Therapy, Faculty of Health and Medical Science, Teikyo Heisei University, 2-51-4 Higashi-Ikebukuro, Toshima-ku, Tokyo, 170-8445, Japan
Graduate School of Humanities and Social Sciences, Hiroshima University, 1-7-1 Kagamiyama, Higashi-Hiroshima City, Hiroshima, 739-8521, Japan

⁎Corresponding author: Junji Nishimoto. nishimoto-j@tokyo-kasei.ac.jp

Disclaimer:
This article was originally published by Reed Elsevier India Pvt. Ltd. and was migrated to Scientific Scholar after the change of Publisher.

Abstract

Abstract

Total hip arthroplasty (THA) is an effective treatment for hip osteoarthritis (OA). The patient acceptable symptom state (PASS) provides meaningful thresholds for patient-reported outcomes. However, short-term PASS after THA remains underexplored, despite its importance in identifying early recovery status, guiding timely postoperative interventions, and supporting patient expectations during the critical early rehabilitation phase. This study aimed to determine short-term PASS thresholds for each Hip disability and Osteoarthritis Outcome Score (HOOS) subscale.

This multicenter prospective cohort study evaluated 150 patients with hip OA who underwent primary unilateral THA. PASS thresholds for the HOOS subscales—symptoms, pain, activities of daily living (ADL), sport and recreation (SR), and quality of life (QOL)—were calculated at 3 and 6 months after THA using both the 25th percentile method and receiver operating characteristic (ROC) analysis, anchored to the Global Rating of Change scale.

At 3 months post-THA, the PASS thresholds (percentile/ROC) were: symptoms 60.0/47.5, pain 70.0/56.3, ADL 60.3/72.8, SR 37.5/28.1, and QOL 37.5/28.1. At 6 months post-THA, the PASS thresholds (percentile/ROC) were: symptoms 70.0/52.5, pain 82.5/72.5, ADL 77.9/72.8, SR 37.5/37.0, and QOL 62.5/46.9.

This study provides preliminary short-term PASS thresholds for the HOOS subscales after THA in patients with hip OA. These early benchmarks may assist clinicians in identifying patients who appear to be experiencing suboptimal recovery as early as 3 months post-THA, potentially enabling timely postoperative support. Short-term PASS thresholds may offer helpful indicators of expected early recovery and support shared decision-making during follow-up. While these findings suggest potential clinical practice value, further studies with larger and more diverse populations are needed to enhance generalizability and confirm applicability.

Keywords

Hip osteoarthritis
Total hip arthroplasty
Hip disability and osteoarthritis outcome score
Patient acceptable symptom state
Patient-reported outcome measures
1

1 Introduction

Total hip arthroplasty (THA) is an effective treatment for severe hip disorders, particularly in patients with end-stage hip osteoarthritis (OA). This procedure relieves pain and improves functional status and quality of life (QOL).1 The evaluation of patient outcomes after THA is essential for optimizing treatment strategies. Patient-reported outcome measures (PROM) are commonly used to assess treatment effectiveness.2 Among these, the Hip disability and Osteoarthritis Outcome Score (HOOS) is a highly reliable, valid, and responsive tool that is widely applied in clinical settings to evaluate postoperative outcomes.3–5 By assessing symptoms, pain, activities of daily living (ADL), sport and recreation (SR), and QOL, HOOS is internationally recommended for THA outcome assessment.6

In recent years, the patient acceptable symptom state (PASS) has gained attention as an indicator for evaluating the therapeutic effects of THA from the patient's perspective.7 This approach dichotomizes PROM results, allowing clinicians to interpret outcomes not only in terms of average improvement but also in relation to whether patients have reached a personally satisfactory state. PASS refers to the threshold score that distinguishes patients who consider their current state acceptable from those who do not.7 Previous studies have reported PASS thresholds for individual HOOS subscales; for example, at 1 year post-THA, the PASS thresholds for pain, physical function short form, and QOL have been reported as 91, 88, and 83, respectively.8 Furthermore, a study using the HOOS Joint Replacement (JR) reported a PASS threshold of 76.7 at 2 years post-THA.9 Additionally, when examined by preoperative diagnosis, the PASS thresholds for HOOS-pain and HOOS-JR in patients with OA were 80.6 and 76.8, respectively, whereas those in patients without OA were 77.5 and 73.5, respectively.10 These previous studies suggest that PASS scores after THA vary according to patient characteristics, timing of assessment, and the subscales used.

Most previous studies have focused on mid-to long-term outcomes (≥1 year postoperatively), and the PASS threshold during the early recovery phase (including 3–6 months) remains unclear.8,9 The early postoperative phase represents the most critical period for clinical decision-making, rehabilitation adjustment, and patient counseling. At this stage, clinicians must judge whether a patient's recovery trajectory is acceptable or delayed, often without concrete patient-centered benchmarks. Importantly, PASS thresholds derived from mid- or long-term outcomes—particularly those based on single composite indices, such as HOOS-JR—may not be directly extrapolated to the early postoperative phase because symptom burden, functional priorities, and patient expectations differ fundamentally between early and late recovery.

No studies have established short-term PASS thresholds for each HOOS subscale after THA. This is clinically important because symptoms, pain, ADL, SR, and QOL recover at different speeds and contribute differently to early postoperative satisfaction. Reliance on a single composite score, such as the HOOS-JR, may obscure domain-specific recovery patterns and limit individualized rehabilitation planning. Therefore, the establishment of subscale-specific short-term PASS thresholds provides novel, domain-sensitive benchmarks that cannot be derived from existing mid- or long-term PASS studies.

Moreover, cultural and regional factors may influence patients’ perceptions of acceptable symptom states. In Japan, THA is predominantly performed in older adults who often have lower preoperative activity levels, place greater emphasis on independence in basic ADL, and typically undergo longer rehabilitation-focused inpatient stays than those in Western countries.11 These sociocultural and healthcare system factors may shape expectations for postoperative function and pain relief, potentially affecting HOOS scoring patterns as well as the symptom levels that patients consider acceptable. Establishing an early postoperative PASS threshold would provide an objective reference, enabling clinicians to identify patients whose recovery is delayed relative to patient-centered expectations.

Clarifying short-term PASS thresholds can support personalized postoperative monitoring by identifying patients who may require extended or modified rehabilitation programs. It can also facilitate timely communication and shared decision-making, for example, by helping clinicians explain recovery progress or prognosis to patients who are anxious about their improvement. Unlike the minimal clinically important difference (MCID), which focuses on the magnitude change in symptoms or function, the PASS represents a specific threshold indicating a state that patients consider satisfactory.7 It serves as a clinically intuitive criterion for judging the adequacy of recovery rather than merely the presence or size of improvement.

This study aimed to establish PASS thresholds for each HOOS subscale during the early postoperative period (3 and 6 months) after THA. These thresholds offer objective criteria for assessing patients’ perceived recovery during this phase, thereby supporting patient-centered monitoring, individualized rehabilitation planning, and effective patient education in clinical settings.

2

2 Materials and methods

2.1

2.1 Ethics

This study adhered to the principles of the Declaration of Helsinki and was approved by the Ethics Review Boards of the authors’ institutions. All assessments were noninvasive and essential for evaluating functional status. Written informed consent was obtained from all participants.

2.2

2.2 Study design

This multicenter, prospective cohort study followed patients for 6 months to assess patient-reported outcomes after THA, focusing on PASS thresholds for each HOOS subscale at 3 and 6 months postoperatively.

2.3

2.3 Setting

This study was conducted in the rehabilitation departments of three facilities located in Japan. At these facilities, the average length of hospital stay for patients undergoing THA was 14 days. Recruitment, follow-up, and data collection were conducted between February 2023 and August 2025.

2.4

2.4 Participants

The study included patients with hip OA who underwent primary unilateral THA and could walk independently before and after surgery, with or without assistive devices. The exclusion criteria were rheumatoid arthritis, systemic lupus erythematosus, dementia, psychiatric disorders, femoral head necrosis, post-THA complications (including deep vein thrombosis and fracture), and revision THA. Patients with these conditions were excluded because of their potential influence on HOOS results.12–18 In addition, patients with missing HOOS responses were excluded from the study.

All participants followed a standardized postoperative rehabilitation program beginning the day after THA. During the inpatient period (approximately the first 2 weeks postoperatively), rehabilitation sessions were provided at least five times per week and included progressive lower-limb resistance exercises, range of motion exercises, gait training, and strengthening exercises for the hip, knee, and ankle. After discharge, patients continued outpatient rehabilitation once per week. The total duration of supervised rehabilitation did not exceed 150 days postoperatively. Key functional milestones during rehabilitation focused on recovery of independence in ADL and ambulation, including improvements in gait stability and achievement of independent walking with or without a walking aid, according to individual recovery status.

2.5

2.5 Variables

The primary outcome was the PASS for the HOOS, assessed at 3 and 6 months post-THA. The HOOS consists of 40 items across five subscales: symptoms, pain, ADL, SR, and QOL.3 The HOOS questionnaire includes five items for symptoms, 10 for pain, 17 for ADL, four for SR, and four for QOL. Each subscale has five response options, with 0 % indicating the worst condition and 100 % indicating the best. HOOS is a highly valid, responsive, and reliable PROM for evaluating outcomes after THA.3,5

2.6

2.6 Statistical analyses

We employed two methods to calculate PASS thresholds: the percentile approach7 and receiver operating characteristic (ROC) analysis. These two approaches were adopted because they capture complementary aspects of PASS. The percentile method directly reflects the distribution of PROM scores among patients who consider their state acceptable and offers a simple and intuitive interpretation from a clinical perspective. By contrast, ROC analysis quantifies the discriminative ability of PROM scores to distinguish between acceptable and unacceptable states by identifying the optimal cut-off based on sensitivity and specificity using the Youden index. Because these two methods rely on different conceptual frameworks, minor discrepancies between the derived thresholds are expected and should be interpreted as reflecting different clinical and statistical perspectives rather than inconsistencies.

We evaluated both the percentile method and ROC analysis using the 11-point Global Rating of Change (GRC) scale (ranging from −5 to +5 points, centered at 0 point) for the HOOS scores at 3 and 6 months post-THA as an anchor. The 11-point GRC scale has high discriminative power.19 In accordance with prior validation studies, a change score of ≥ +2 on the GRC was defined as a clinically meaningful improvement, as this threshold represents the minimal level at which patients can reliably perceive meaningful recovery.19 For the percentile method, the 25th percentile value was calculated as the PASS threshold for patients who selected +2 or higher on the GRC scale. ROC analysis was performed by classifying patients who achieved a score of +2 or higher on the 11-point GRC scale for each HOOS subscale into an improvement group, and those who achieved a score of +1 or lower into the non-improvement group.19 The PASS threshold was determined using the Youden index.20 All statistical analyses were performed using IBM SPSS Statistics version 29.0 (IBM Corp., Armonk, NY, USA).

2.7

2.7 Sample size

The required sample size was determined using MedCalc statistical software version 23.3.2 (MedCalc Software bvba, Ostend, Belgium). The parameters were set at a significance level of P <0.05, statistical power of 0.8, and a null hypothesis ROC value of 0.5. The area under the curve (AUC) values were interpreted as follows: non-predictive (AUC <0.5), low predictive capacity (0.5≤ AUC <0.7), moderate predictive capacity (0.7≤ AUC <0.9), high predictive capacity (0.9≤ AUC <1), and perfect prediction (AUC = 1).21,22 Based on previous PASS studies after THA reporting AUC values in the range of approximately 0.80–0.90, an expected AUC of 0.80 was adopted as a conservative estimate for this study.8 The allocation ratio was determined based on the proportions of positive and negative groups reported in previous studies after THA. The proportions of positive and negative cases were set to 0.94 and 0.06, respectively.8 Under these assumptions, the minimum required sample size was calculated to be 101 participants (94 positive cases, 7 negative cases).

3

3 Results

3.1

3.1 Cohort characteristics

Of the 195 patients scheduled for THA, 45 were excluded because of rheumatoid arthritis (n = 7), systemic lupus erythematosus (n = 2), dementia (n = 4), psychiatric disorders (n = 1), femoral head necrosis (n = 24), bilateral THA (n = 2), or revision THA (n = 5). Consequently, 150 patients were included in the analysis (Fig. 1). At 3 months post-THA, 20 of the 150 eligible patients were excluded because of complications (n = 1), contralateral THA (n = 1), or missing HOOS (n = 18), leaving 130 patients for analysis. At 6 months post-THA, 10 patients were excluded from the 130 eligible patients because of contralateral THA (n = 5) or missing HOOS (n = 5), leaving 120 patients for analysis. The demographic and clinical characteristics of the participants are shown in Table 1.

Flow diagram. HOOS, Hip disability and Osteoarthritis Outcome Score; THA, total hip arthroplasty.
Fig. 1 Flow diagram. HOOS, Hip disability and Osteoarthritis Outcome Score; THA, total hip arthroplasty.
Table 1 Baseline patient characteristics.
THA study cohort
Variables (n = 150)
Age 69.00 ± 9.13
Female, n (%) 141 (94.00)
Height (cm) 153.38 ± 6.71
Weight (kg) 60.14 ± 12.31
BMI (kg/m2) 25.52 ± 4.76
WHO classification of obesity, n (%)
Underweight 7 (4.67)
Normal weight 73 (48.67)
Pre-obese 49 (32.67)
Obese class I 14 (9.33)
Obese class II 5 (3.33)
Obese class III 2 (1.33)
ASA, n (%)
1 14 (9.33)
2 113 (75.33)
3 22 (14.67)
4 1 (0.67)
CCI, n (%)
0 131 (87.33)
1–2 19 (12.67)
≥3 0 (0)
Surgical approach, n (%)
Anterolateral approach 128 (85.33)
Direct lateral approach 6 (4.00)
Posterolateral approach 16 (10.67)
Fixation method, n (%)
Cementless 146 (97.33)
Cemented 4 (2.67)
Femoral stem length, n (%)
Short 110 (73.33)
Standard 40 (26.67)
Bearing surface, n (%)
Ceramic-on-polyethylene 146 (97.33)
Metal-on-polyethylene 4 (2.67)
3.2

3.2 PASS thresholds

The mean and standard deviation of each HOOS subscale score at the preoperative, 3-month, and 6-month postoperative assessments are presented in Table 2. The detailed PASS thresholds for each HOOS subscale are presented in Tables 3 and 4. Overall, the PASS thresholds increased from 3 to 6 months after THA, reflecting a progressive improvement in patients’ perceived symptom acceptability. The diagnostic accuracy of PASS at 3 months postoperatively was excellent for pain (AUC = 0.96), good for symptoms (AUC = 0.84), ADL (AUC = 0.84), QOL (AUC = 0.84), and fair for SR (AUC = 0.75) (Table 3). At 6 months, the accuracy was excellent for symptoms (AUC = 0.99), pain (AUC = 0.98), ADL (AUC = 0.96), and QOL (AUC = 0.95), and fair for SR (AUC = 0.72) (Table 4).

Table 2 HOOS subscale scores pre-THA and at 3 and 6 months post-THA.
HOOS Pre-THA 3 months post-THA 6 months post-THA
Symptoms 37.17 ± 21.15 69.81 ± 18.80 77.06 ± 18.18
Pain 41.98 ± 19.89 77.19 ± 19.45 86.56 ± 15.83
ADL 38.08 ± 20.00 72.04 ± 17.42 82.43 ± 17.42
SR 17.32 ± 19.85 43.03 ± 25.95 51.14 ± 25.95
QOL 23.15 ± 14.74 55.91 ± 22.96 65.78 ± 22.96
Table 3 Cut-off values for HOOS at 3 months post-THA.
HOOS 25th percentile 95 % CI Youden index Sensitivity Specificity AUC 95 % CI P value
Symptoms 60.00 55.00–65.00 47.50 0.92 0.38 0.84 0.70-0.98 <0.001
Pain 70.00 62.50–74.94 56.25 0.90 1.00 0.96 0.93-1.00 <0.001
ADL 60.29 60.29–64.71 72.80 0.57 1.00 0.84 0.71-0.97 <0.001
SR 37.50 25.00–37.50 28.13 0.83 0.60 0.75 0.66-0.85 <0.001
QOL 37.50 37.50-43.75 28.13 0.87 0.67 0.84 0.71-0.98 <0.001
Table 4 Cut-off values for HOOS at 6 months post-THA.
HOOS 25th percentile 95 % CI Youden index Sensitivity Specificity AUC 95 % CI P value
Symptoms 70.00 65.00–75.00 52.50 0.93 1.00 0.99 0.97-1.01 <0.001
Pain 82.50 82.50–87.50 72.50 0.89 1.00 0.98 0.94-1.02 <0.001
ADL 77.94 76.47–80.88 72.80 0.86 1.00 0.96 0.90-1.01 <0.001
SR 37.50 25.00–37.50 37.00 0.80 0.73 0.72 0.56-0.88 0.007
QOL 62.50 50.00–62.50 46.88 0.86 1.00 0.95 0.90-1.00 <0.001
4

4 Discussion

This study identified the PASS thresholds for each HOOS subscale at 3 and 6 months after THA in patients with hip OA. At 3 months post-THA, the PASS thresholds calculated using the percentile method were 60.00 for symptoms, 70.00 for pain, and 60.29 for ADL, whereas SR and QOL showed lower values of 37.50. At 6 months post-THA, the PASS thresholds for symptoms, pain, ADL, and QOL each increased compared with those at 3 months post-THA, whereas the SR remained at 37.50. Furthermore, in the ROC analysis evaluating discriminatory ability, the AUC for HOOS pain at 3 months post-THA was exceptionally high at 0.96, while symptoms, ADL, and QOL also showed favorable values at 0.84. By contrast, SR yielded a lower value of 0.75. Similarly, at 6 months post-THA, the AUCs for symptoms, pain, ADL, and QOL were all 0.95 or higher, indicating excellent discriminatory ability; however, the AUC for SR was low at 0.72.

A comparison of the PASS thresholds obtained in this study with the mid-to long-term outcomes reported in previous studies revealed several noteworthy differences. In a study by Emara et al., the PASS threshold calculated using ROC analysis at 1 year post-THA was higher than the PASS thresholds at 3 and 6 months post-THA observed in this study.10 In a study by Paulsen et al., the PASS thresholds identified using the percentile method at 1 year post-THA were calculated as 91 for pain and 83 for QOL.8 These values exceeded the corresponding PASS thresholds obtained in this study at 6 months post-THA (pain 82.50, QOL 62.50). Considering the results of these previous studies, it is suggested that the PASS threshold in the early post-THA period (3 or 6 months) should be set lower than that in the 1- or 2-years post-THA period. Indeed, in a study by Galea et al., the PASS threshold for the Oxford Hip Score was 34 points at 3 months post-THA, 40 points at 1 year, and 39 points at 2 years, indicating a lower PASS threshold at the 3-month time point.23 Collectively, these findings suggest that patients tend to set higher standards for what they consider acceptable as recovery progresses after THA, requiring correspondingly higher HOOS scores to perceive their condition as satisfactory.

In addition to differences in follow-up duration, several other factors may have contributed to the discrepancies between the short-term PASS thresholds observed in this study and the higher thresholds reported in previous long-term studies. Methodological variations, including differences in anchor questions, cut-off determination methods (percentile vs. ROC-based approaches), and outcome instruments, may influence PASS estimation. Furthermore, patient characteristics, such as older age and lower preoperative activity levels in our cohort, could have led to lower expectations of acceptable symptom states in the early postoperative phase. Differences in healthcare systems, including the longer inpatient rehabilitation periods typical of Japan, may also shape postoperative recovery trajectories and patients' perceptions of acceptability.11 These factors likely interact with timing effects to produce the observed differences in PASS thresholds. Important insights were also gained regarding differences in PASS thresholds across HOOS subscales. In particular, for the SR subscale, the PASS thresholds at both 3 and 6 months post-THA were substantially lower than those observed for the other HOOS subscales, and the corresponding AUC values were comparatively reduced. This finding suggests that limitations in sports and recreation during the early postoperative period may not strongly influence patients’ overall subjective acceptance of their condition. However, these observations should be interpreted with caution. Although older age has been associated with lower HOOS-SR scores in previous studies, expectations for sports and recreation were not directly assessed in our cohort.24 Therefore, the relatively low SR PASS thresholds observed in this study cannot be solely attributed to age-related differences in expectations. Other factors, such as lower preoperative activity levels, prioritization of pain relief and basic daily function during early recovery, and potential measurement characteristics of the SR subscale, may also contribute to this finding.25

The clinical implications of this study are multifaceted. A key implication of this study is that identifying PASS thresholds during the early postoperative period provides a practical benchmark for evaluating patient-perceived recovery. By establishing percentile-based PASS thresholds for each HOOS subscale, clinicians can more effectively recognize patients who may perceive their condition as unacceptable even after surgery. Such cases may warrant closer monitoring, reassessment of pain control, or modification of rehabilitation programs. Conversely, certain domains, such as SR, may not strongly influence patient satisfaction in older adults during the early postoperative phase, suggesting that treatment goals should be tailored to individual expectations and activity levels. Using PASS as a reference enables clinicians to assess subjective recovery more objectively, detect potential problems early, and implement timely interventions. Unlike evaluations based solely on mean scores or statistical significance, PASS directly reflects patient satisfaction and offers valuable guidance for patient-centered postoperative care.26 Furthermore, integrating PASS-based assessment into follow-up may enhance shared decision-making and promote individualized rehabilitation strategies after THA.

The primary strength of this study was the first calculation of PASS thresholds using HOOS subscales during the short-term period after THA in patients with hip OA. The ability to clarify treatment effects at an earlier stage would be beneficial to both clinicians and patients, contributing considerably to patient-centered care. Nevertheless, this study has several limitations. First, the sample size was insufficient to ensure broad generalizability. Although the sample size allowed validation of a moderate predictive value, the findings may not represent the entire population of patients undergoing THA worldwide. The study cohort showed a marked female predominance (94 %), which reflects the epidemiology of hip OA and THA in Japan, but may limit the generalizability of the present findings, particularly to male patients.27 In addition, because the present cohort consisted primarily of older adults, the PASS thresholds identified in this study, particularly those for the SR subscale, may not be generalizable to younger or more physically active THA populations, who typically have different postoperative expectations and recovery goals. Moreover, this study focused exclusively on short-term outcomes at 3 and 6 months postoperatively, and long-term PASS comparisons within the same cohort were unavailable. PASS thresholds are known to evolve over time as symptoms improve and patient expectations change; therefore, longitudinal assessment within individuals would provide important insights into the temporal trajectory and stability of acceptable symptom states after THA. Collectively, future studies incorporating larger and more diverse samples with balanced sex distributions and broader age ranges, as well as extended longitudinal follow-up, are needed to enhance generalizability and to compare short-, mid-, and long-term PASS thresholds within the same cohort. Second, important confounders that may influence HOOS outcomes, such as socioeconomic status, preoperative functional status, physical activity level, and postoperative rehabilitation intensity, were not fully adjusted for in this analysis. Lower educational levels have been associated with worse pain and physical function,28 and inactive patients undergoing THA experience greater improvements in physical activity levels than those who were active before surgery.25 In addition, variations in baseline functional severity and the intensity or adherence to rehabilitation programs may substantially affect postoperative recovery trajectories. The lack of comprehensive adjustment for these confounders limits the strength of the causal interpretations drawn from the present findings. Third, potential cultural influences on PROM interpretation should be considered. The present cohort consisted entirely of Japanese patients, whose expectations regarding pain relief, independence in ADL, and SR participation may differ from those of Western populations because of sociocultural norms and healthcare system characteristics. These factors may affect how acceptable symptom states are perceived and limit the direct cross-cultural comparability of PASS thresholds. Fourth, attrition resulting from missing HOOS responses, particularly at 3 months postoperatively, may have reduced the robustness of the findings and introduced the potential for non-response bias. Most missing data were attributed to logistical follow-up issues after hospital discharge and incomplete questionnaire returns rather than clinical deterioration. Future studies should implement structured follow-up strategies, such as electronic PROM systems, automated reminders, and centralized data monitoring, to improve response rates and minimize bias. Fifth, the PASS was anchored solely to the GRC scale, and objective functional recovery markers, such as hip range of motion, muscle strength, and gait performance, were not available for triangulation. Although the GRC scale is widely used and conceptually aligned with the patient-centered definition of PASS, the lack of objective anchors may limit the multidimensional validation of acceptable recovery. Future studies that integrate PROM-based PASS with objective physical performance measures would allow for more robust and comprehensive assessments. Finally, we were unable to adjust for the surgical approach or implant characteristics used in the analysis. Because differences in surgical techniques and implant-related factors may influence postoperative pain relief and the speed of functional recovery, future studies should incorporate appropriate adjustment for these variables.29,30

5

5 Conclusions

This study identified short-term PASS thresholds for HOOS after THA in patients with hip OA. These thresholds provide clinicians with practical benchmarks to detect unsatisfactory recovery as early as 3 months after THA and to adjust pain management and rehabilitation strategies accordingly. For patients, PASS offers clear and understandable indicators of acceptable recovery, supporting realistic expectations and shared decision-making in the early THA follow-up period.

Ethical statement

This study was conducted in accordance with the Declaration of Helsinki. The protocol was reviewed and approved by the Ethics Committee of Saitama Medical Center, Saitama Medical University, which served as the central review board and provided approval covering all participating investigators and sites (approval number: E2022-109). Written informed consent was obtained from all participants.

CRediT authorship contribution statement

Junji Nishimoto: Conceptualization, Methodology, Formal analysis, Investigation, Resources, Data Curation, Writing – original draft, Visualization, Supervision, Project administration. Rikumi Kurahashi: Investigation, Data curation, Writing – review & editing. Kotaro Tamari: Methodology, Writing –review & editing. Ryo Tanaka: Methodology, Writing – review & editing.

Funding

The authors received no financial support for the research, authorship, and publication of this article.

References

  1. , , , . Associations between pain, function and quality of life after total hip arthroplasty. Int J Orthop Trauma Nurs. 2024;54
    [Google Scholar]
  2. , , , , . Outcome measures in total hip arthroplasty: have our metrics changed over 15 years? Arch Orthop Trauma Surg. 2022;142:1753-1762.
    [Google Scholar]
  3. , , , , . Hip disability and osteoarthritis outcome score (HOOS) - validity and responsiveness in total hip replacement. BMC Musculoskelet Disord. 2003;4:10.
    [Google Scholar]
  4. , , , , , . Validity, reliability and responsiveness of patient-reported outcome questionnaires when assessing hip and groin disability: a systematic review. Br J Sports Med. 2010;44(16):1186-1196.
    [Google Scholar]
  5. , , , , . Cross-cultural adaptation and validation reliability, validity of the Japanese version of the hip disability and osteoarthritis Outcome Score (HOOS) in patients with hip osteoarthritis. Osteoarthr Cartil. 2013;21(4):570-573.
    [Google Scholar]
  6. , . Patient reported outcomes in hip arthroplasty registries. Dan Med J. 2014;61(5)
    [Google Scholar]
  7. , , , , , , . Patient acceptable symptom state (PASS): thresholds for the EQ-5D-5L and Oxford hip and knee scores for patients with total hip and knee replacement. Qual Life Res. 2023;32:519-530.
    [Google Scholar]
  8. , , , , . Minimal clinically important improvement (MCII) and patient-acceptable symptom state (PASS) in total hip arthroplasy (THA) patients 1 year postoperatively. Acta Orthop. 2014;85(1):39-48.
    [Google Scholar]
  9. , , , , , . Defining the patient acceptable symptom State for the HOOS JR and KOOS JR after primary total joint arthroplasty. J Bone Joint Surg Am. 2022;104(4):345-352.
    [Google Scholar]
  10. , , , et al . What are the diagnosis-specific thresholds of minimal clinically important difference and patient acceptable symptom state in Hip Disability and Osteoarthritis Outcome Score after primary total hip arthroplasty? J Arthroplast. 2024;39(7):1783-1788.e2.
    [Google Scholar]
  11. , , , et al . Standard table direct anterior approach within an early discharge protocol for cementless total hip arthroplasty: experience from a Japanese hospital. J Med Econ. 2021;24(1):394-401.
    [Google Scholar]
  12. , , , , , , . Risk factors associated with short-term clinical results after total hip arthroplasty for patients with rheumatoid arthritis. Orthopedics. 2018;41(6):e772-e776.
    [Google Scholar]
  13. , , , et al . Patients with systemic lupus erythematosus have increased risk of short-term adverse events after total hip arthroplasty. J Rheumatol. 2016;43(8):1498-1502.
    [Google Scholar]
  14. , , , et al . Cognitive impairment and postoperative outcomes in patients undergoing primary total hip arthroplasty: a systematic review. J Clin Anesth. 2019;56:65-76.
    [Google Scholar]
  15. , , , , . Preoperatively predicting failure to achieve the minimum clinically important difference and the substantial clinical benefit in patient-reported outcome measures for total hip arthroplasty patients using machine learning. BMC Musculoskelet Disord. 2025;26:150.
    [Google Scholar]
  16. , , , et al . Patient-reported outcomes after primary or revision total hip arthroplasty: a propensity score-matched Asian cohort study. PLoS One. 2021;16(5)
    [Google Scholar]
  17. , , , , . National trends in deep vein thrombosis following total knee and total hip replacement in the United States. Ann Vasc Surg. 2017;38:310-314.
    [Google Scholar]
  18. , , , et al . Undetected intraoperative periprosthetic femoral fractures in patients undergoing primary total hip arthroplasty: a retrospective case series and literature review. Orthop Surg. 2023;15(3):758-765.
    [Google Scholar]
  19. , , , . Global rating of change scales: a review of strengths and weaknesses and considerations for design. J Man Manip Ther. 2009;17(3):163-170.
    [Google Scholar]
  20. , , , . Estimation of the Youden index and its associated cutoff point. Biom J. 2005;47(4):458-472.
    [Google Scholar]
  21. , . Measuring the accuracy of diagnostic systems. Science. 1988;240(4857):1285-1293.
    [Google Scholar]
  22. , , , , . Minimal clinically important differences in short-term postoperative Knee injury and Osteoarthritis Outcome Score (KOOS) after total knee arthroplasty: a prospective cohort study. Journal of Orthopaedics, Trauma and Rehabilitation. 2023;31(1):15-20.
    [Google Scholar]
  23. , , , et al . Patient-acceptable symptom state for the Oxford Hip Score and Forgotten Joint Score at 3 months, 1 year, and 2 years following total hip arthroplasty: a registry-based study of 597 cases. Acta Orthop. 2020;91(4):372-377.
    [Google Scholar]
  24. , , , , , . Age-related decline in patient-reported outcomes 2 and 5 years following total hip arthroplasty. J Arthroplast. 2019;34(9):1999-2005.
    [Google Scholar]
  25. , , , , , , . Does physical activity level influence total hip arthroplasty expectations, satisfaction, and outcomes? J Arthroplast. 2021;36(8):2850-2857.
    [Google Scholar]
  26. , , , , , . Patient acceptable symptom state in self-report questionnaires and composite clinical disease index for assessing rheumatoid arthritis activity: identification of cut-off points for routine care. BioMed Res Int. 2015;2015
    [Google Scholar]
  27. , , , et al . Life course epidemiology of hip osteoarthritis in Japan: a multicenter, cross-sectional study. J Bone Joint Surg Am. 2024;106(11):966-975.
    [Google Scholar]
  28. , , , , . A systematic review of preoperative determinants of patient-reported pain and physical function up to 2 years following primary unilateral total hip arthroplasty. Orthop Traumatol Surg Res. 2016;102(3):397-403.
    [Google Scholar]
  29. , , , et al . Similar superior patient-reported outcome measures for anterior and posterolateral approaches after total hip arthroplasty: postoperative patient-reported outcome measure improvement after 3 months in 12,774 primary total hip arthroplasties using the anterior, anterolateral, straight lateral, or posterolateral approach. J Arthroplast. 2018;33(6):1786-1793.
    [Google Scholar]
  30. , , , , . Functional outcome of direct anterior versus posterior approach in total hip arthroplasty: a propensity-matched Asian study. Singapore Med J 2024
    [Google Scholar]
Show Sections